Lindsay A, Hickman D, Srinivasan M. A nuclear factor-kappa B inhibiting peptide suppresses innate immune receptors and gliosis in a transgenic mouse model of Alzheimer’s disease. Biomedicine and Pharmacotherapy. 2021.
Nuclear factor-kappa B: Glucocorticoid-induced leucine zipper interface analogs suppress pathology in an Alzheimer's disease model. Alzheimer's & Dementia: Translational Research & Clinical Interventions, Volume 4, 2018, Pages 488-498.
https://www.trci.alzdem.com/article/S2352-8737(18)30022-2/abstract
https://www.ncbi.nlm.nih.gov/pubmed/30338290
Glucocorticoid Induced Leucine Zipper in Lipopolysaccharide Induced Neuroinflammation. Front Aging Neurosci. 2019 Jan 25;10:432.
https://dx.doi.org/10.3389%2Ffnagi.2018.00432
Glucocorticoid-Induced Leucine Zipper in Central Nervous System Health and Disease. Mol Neurobiol. 2017;54(10):8063–8070.
https://www.ncbi.nlm.nih.gov/pubmed/27889894
Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis:
https://www.ncbi.nlm.nih.gov/pubmed/25652642
Novel Nuclear Factor-KappaB Targeting Peptide Suppresses β-Amyloid Induced Inflammatory and Apoptotic Responses in Neuronal Cells. PLoS One. 2016;11(10):e0160314.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072831/
Functional characterization of a competitive peptide antagonist of p65 in human macrophage-like cells suggests therapeutic potential for chronic inflammation:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262379/
CD80 Blockade Enhance Glucocorticoid-Induced Leucine Zipper Expression and Suppress Experimental Autoimmune Encephalomyelitis: